Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CPSC leadership

This article was originally published in The Tan Sheet

Executive Summary

Nomination of Harold Stratton to chair Consumer Product Safety Commission, take over as commissioner for remainder of term expiring Oct. 26, 2006, sent to the Senate March 13. Nomination will go before the Commerce Committee; no confirmation hearings have been scheduled. Bush Administration announced its choice in November, after Mary Sheila Gall's nomination was defeated by Senate Democrats (1"The Tan Sheet" Nov. 5, 2001, In Brief)...

You may also be interested in...



CPSC

President Bush nominates Harold Stratton to chair Consumer Product Safety Commission. Albuquerque lawyer is "known consumer advocate" who served as New Mexico's AG (1987-1990) and in state's House of Representatives (1979-1986), White House says. Stratton is a partner with the law firm Stratton & Cavin. No Senate confirmation hearings have been scheduled. Bush Administration abandoned its push to appoint Mary Sheila Gall as commission chair after her nomination was defeated in committee by Senate Democrats (1"The Tan Sheet" Aug. 6, p. 6). Commissioner Thomas Moore named acting chairman after Ann Brown's previously announced resignation took effect Nov. 1...

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093749

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel